You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 68 No. 1, JULY 1941 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

TREATMENT OF LOBAR PNEUMONIA WITH RABBIT ANTIPNEUMOCOCCUS SERUM

EFFICACY OF THE PROJECTED DOSE METHOD OF TREATING PNEUMONIA WITH HOMOLOGOUS REFINED AND UNCONCENTRATED RABBIT ANTIPNEUMOCOCCUS SERUM

ELMER H. LOUGHLIN, M.D.; SAMUEL H. SPITZ, M.D.; RICHARD H. BENNETT, M.D.

Arch Intern Med. 1941;68(1):121-133.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

During the past year pneumococcic pneumonia was treated almost exclusively with chemotherapeutic substances. Pneumonia during this period was relatively mild, and bacteremia was infrequent. A decreased mortality rate for pneumonia, which could not be attributed entirely to specific measures, was noted. We feel, therefore, that a study of the results obtained with a specific therapeutic agent during a previous period in which pneumonia was known to be more severe and in which there was a higher incidence of bacteremia should be presented at this time.

Rabbit antipneumococcus serum was first used by Horsfall, Goodner and MacLeod1 in 1936. In 1937, these authors and an associate2 described 22 cases in which this serum was used. In 1938, the first three authors reported the results obtained with homologous serum in 67 cases of types I, II, III, V, VI, VII, VIII, XIV and XVIII pneumococcus pneumonia in which the mortality . . . [Full Text PDF of this Article]


Author Affiliations

BROOKLYN

From the Department of Internal Medicine, Long Island College of Medicine.


Footnotes

The rabbit antipneumococcus serum used in the cases reported in this paper was supplied by the Lilly Research Laboratories.

This work was made possible by a fellowship grant from the Lilly Research Laboratories, Indianapolis, and by aid from the Dr. Frank E. West Fund, established by Miss Elizabeth Frothingham, and from the John C. Warren Memorial Fund, established by Dr. Luther F. Warren, in memory of his son.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1941 American Medical Association. All Rights Reserved.